GSK PLC ADR Cert.Deposito Arg.Repr. 0.25 ADRsGSK PLC ADR Cert.Deposito Arg.Repr. 0.25 ADRsGSK PLC ADR Cert.Deposito Arg.Repr. 0.25 ADRs

GSK PLC ADR Cert.Deposito Arg.Repr. 0.25 ADRs

İşlem yok
Süper-grafiklerde görün

GSKD tahvilleri

Aşağıda GSK PLC ADR Cert.Deposito Arg.Repr. 0.25 ADRs şirket tahvillerinin listesi bulunmaktadır. Yatırımcılar genellikle piyasa dalgalanması zamanlarında artan istikrarları için bir şirketin tahvillerini tercih ederler. Fiyatları, getirileri ve diğer istatistikleri inceleyin ve güvenilir bir yatırım bulun.
Sembol
Vade sonu getirisi %
Hacim
Fiyat %
Kupon %
Vade Tarihi
Ödenmemiş tutar
Nominal değer
Asgari brm tutarı
İhraççı
GGSK3981911GlaxoSmithKline Capital, Inc. 4.2% 18-MAR-2043
160 K86,19%4,20%2043-03-18500 M USD1.000,00 USD2.000,00 USDGlaxoSmithKline Capital, Inc.
GGSK6023695GlaxoSmithKline Capital, Inc. 4.5% 15-APR-2030
292 K101,17%4,50%2030-04-15850 M USD1.000,00 USD2.000,00 USDGlaxoSmithKline Capital, Inc.
GGSK6023691GlaxoSmithKline Capital Plc 4.315% 12-MAR-2027
3,81 M100,60%4,32%2027-03-12400 M USD1.000,00 USD2.000,00 USDGlaxoSmithKline Capital Plc
GGSK6023692GlaxoSmithKline Capital Plc FRN 12-MAR-2027
627 K100,34%4,86%2027-03-12600 M USD1.000,00 USD2.000,00 USDGlaxoSmithKline Capital Plc
GGSK.GJGlaxoSmithKline Capital, Inc. 6.375% 15-MAY-2038
62 K111,43%6,38%2038-05-152,75 B USD1.000,00 USD2.000,00 USDGlaxoSmithKline Capital, Inc.
GGSK6023693GlaxoSmithKline Capital, Inc. 4.875% 15-APR-2035
375 K100,14%4,88%2035-04-15750 M USD1.000,00 USD2.000,00 USDGlaxoSmithKline Capital, Inc.
XXS182282979GlaxoSmithKline Capital Plc 1.75% 21-MAY-2030
095,27%1,75%2030-05-21750 M EUR1.000,00 EUR100.000,00 EURGlaxoSmithKline Capital Plc
XXS255381776GSK Capital BV 3.125% 28-NOV-2032
099,57%3,13%2032-11-28700 M EUR1.000,00 EUR100.000,00 EURGSK Capital BV
XXS217060184GlaxoSmithKline Capital Plc 1.25% 12-OCT-2028
091,56%1,25%2028-10-12750 M GBP1.000,00 GBP100.000,00 GBPGlaxoSmithKline Capital Plc
XXS217060907GlaxoSmithKline Capital Plc 1.625% 12-MAY-2035
072,52%1,63%2035-05-12750 M GBP1.000,00 GBP100.000,00 GBPGlaxoSmithKline Capital Plc
UUS377373AH8GlaxoSmithKline Capital Plc 3.375% 01-JUN-2029
097,46%3,38%2029-06-011 B USD1.000,00 USD2.000,00 USDGlaxoSmithKline Capital Plc
XXS182282812GlaxoSmithKline Capital Plc 1.25% 21-MAY-2026
099,32%1,25%2026-05-211 B EUR1.000,00 EUR100.000,00 EURGlaxoSmithKline Capital Plc
XXS293369275GSK Capital BV 3.25% 19-NOV-2036
097,01%3,25%2036-11-19600 M EUR1.000,00 EUR100.000,00 EURGSK Capital BV
XXS255381768GSK Capital BV 3.0% 28-NOV-2027
0101,19%3,00%2027-11-28500 M EUR1.000,00 EUR100.000,00 EURGSK Capital BV
UUS377372AN7GlaxoSmithKline Capital, Inc. 3.875% 15-MAY-2028
099,55%3,88%2028-05-151,75 B USD1.000,00 USD2.000,00 USDGlaxoSmithKline Capital, Inc.
GGX5BGlaxoSmithKline Capital Plc 1.0% 12-SEP-2026
098,75%1,00%2026-09-12700 M EUR1.000,00 EUR100.000,00 EURGlaxoSmithKline Capital Plc
XXS168152035GlaxoSmithKline Capital Plc 1.375% 12-SEP-2029
095,24%1,38%2029-09-12500 M EUR1.000,00 EUR100.000,00 EURGlaxoSmithKline Capital Plc
XXS293369143GSK Capital BV 2.875% 19-NOV-2031
099,03%2,88%2031-11-19700 M EUR1.000,00 EUR100.000,00 EURGSK Capital BV
AAG99GlaxoSmithKline Capital Plc 5.25% 19-DEC-20330102,98%5,25%2033-12-19574,17 M GBP1.000,00 GBP1.000,00 GBPGlaxoSmithKline Capital Plc
772WIGlaxoSmithKline Capital, Inc. 5.375% 15-APR-20340105,28%5,38%2034-04-15500 M USD1.000,00 USD1.000,00 USDGlaxoSmithKline Capital, Inc.
771ZCGlaxoSmithKline Capital Plc 6.375% 09-MAR-20390106,50%6,38%2039-03-09631,3 M GBP1.000,00 GBP50.000,00 GBPGlaxoSmithKline Capital Plc
117RNGlaxoSmithKline Capital Plc 3.375% 20-DEC-20270112,19%3,38%2027-12-20307,77 M GBP1.000,00 GBP100.000,00 GBPGlaxoSmithKline Capital Plc
AAQ72GlaxoSmithKline Capital Plc 0.883% 21-SEP-20280,88%2028-09-2142,5 B JPY100.000.000,00 JPY100.000.000,00 JPYGlaxoSmithKline Capital Plc
117RIGlaxoSmithKline Capital Plc 4.25% 18-DEC-20458,46 K82,51%4,25%2045-12-18370,79 M GBP1.000,00 GBP100.000,00 GBPGlaxoSmithKline Capital Plc
883GIGlaxoSmithKline Capital Plc 5.25% 10-APR-2042093,38%5,25%2042-04-10477,82 M GBP1.000,00 GBP50.000,00 GBPGlaxoSmithKline Capital Plc